Advances in diagnostics and therapy of melanoma and other skin cancers 2024 - Virtual Meeting 1

16:30 – 16:45

When to use adjuvant or neoadjuvant therapy in locoregional melanoma? Piotr Rutkowski

15 min

16:45 – 17:00

When to use combined immunotherapy (ipilimumab and nivolumab or nivolumab and relatlimab) or anti-PD-1 monotherapy in treatment of advanced melanomas? Mario Mandala

15 min

17:00 – 17:15

Current role of BRAF and MEK inhibitors Katarzyna Kozak

15 min

17:15 – 17:25

Discussion

10 min

17:25 – 17:55

Challenging cases

30 min

17:25 - 17:35

Case report under the patronage of Pierre Fabre Medicament: Long responders after encorafenib and binimetinib treatment in BRAF V600 advanced melanoma patients Anna M. Czarnecka

17:35 - 17:45

Choice of I line treatment after progression during adjuvant therapy Alice Indini

17:45 - 17:55

Case report under the patronage of MSD: The importance of adjuvant immunotherapy in stage III melanoma Anna M. Czarnecka

17:55 – 18:05

Discussion

10 min